Parallel Advisors LLC Sells 910 Shares of Colgate-Palmolive (NYSE:CL)

Parallel Advisors LLC reduced its holdings in shares of Colgate-Palmolive (NYSE:CL) by 1.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 89,538 shares of the company’s stock after selling 910 shares during the quarter. Parallel Advisors LLC’s holdings in Colgate-Palmolive were worth $8,140,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Kohmann Bosshard Financial Services LLC bought a new position in shares of Colgate-Palmolive during the fourth quarter valued at $26,000. Centricity Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive during the 4th quarter valued at about $27,000. Union Bancaire Privee UBP SA bought a new position in shares of Colgate-Palmolive in the 4th quarter worth approximately $32,000. Briaud Financial Planning Inc purchased a new stake in Colgate-Palmolive during the fourth quarter valued at approximately $32,000. Finally, Wintrust Investments LLC bought a new position in Colgate-Palmolive in the fourth quarter worth approximately $33,000. 80.41% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on CL shares. Morgan Stanley reduced their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. Stifel Nicolaus reduced their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research report on Monday, February 3rd. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Friday. UBS Group cut their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Finally, Barclays cut their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $101.72.

Colgate-Palmolive Stock Down 0.8 %

NYSE CL opened at $89.80 on Monday. The stock’s 50 day moving average is $89.02 and its 200 day moving average is $94.67. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The stock has a market cap of $72.87 billion, a PE ratio of 25.51, a P/E/G ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the business posted $0.87 EPS. Research analysts predict that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.